Medtronic executives said in the company's Aug. 23 earnings call that its cranial and spinal technologies business "remains attractive" despite revenue decreasing 7 percent year over year in the first quarter of fiscal year 2023, according to Seeking Alpha.
Spinal Tech
Nexus Spine's leadership appointment and five more key updates from medtech companies since Aug. 17.
Xtant Medical entered an agreement to sell common stock and warrants to investors.
Surgalign's Cortera spinal fixation system received FDA 510(k) clearance, the devicemaker said Aug. 24.
Spineology named Jamison Young CFO, the devicemaker said Aug. 23.
Advertisement
Abbott's Proclaim Plus spinal cord stimulator received FDA approval.
Nexus Spine's PressON posterior lumbar fixation system was launched, the devicemaker said Aug. 23.
Medtronic saw $7.4 billion in revenue in the first quarter of fiscal year 2023, according to results posted Aug. 23.
Theragen's ActaStim-S spine fusion bone growth stimulator system received a U.S. patent.
Zavation Medical Products' Varisync system received FDA 510(k) clearance.